These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2480137)

  • 1. HLA-DR and -DQ epitopes and monoclonal antibody specificity.
    Marsh SG; Bodmer JG
    Immunol Today; 1989 Sep; 10(9):305-12. PubMed ID: 2480137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specificity of anti-HLA class II monoclonal antibodies in cattle.
    Nilsson PR; Marsh SG; Joosten I; Nieuwland MG; Hensen EJ; Grosfeld-Stulemeyer MC; Mikko S; Gelhaus A; Schreuder GM
    Eur J Immunogenet; 1997 Jun; 24(3):211-23. PubMed ID: 9226127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping of an HLA-DR-specific monoclonal antibody produced by using human-mouse transfectant cells.
    Madrigal JA; Ikeda H; Marsh SG; Heyes JM; Kennedy LJ; Trowsdale J; Bodmer JG
    J Immunol; 1989 Dec; 143(12):4084-9. PubMed ID: 2480386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.
    Marrari M; Duquesnoy RJ
    Tissue Antigens; 2009 Aug; 74(2):134-46. PubMed ID: 19497040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of chimeric anti-HLA monoclonal antibodies targeting public epitopes as tools for standardizations of the anti-HLA antibody detection.
    Congy-Jolivet N; Drocourt D; Portet S; Tiraby G; Blancher A
    J Immunol Methods; 2013 Apr; 390(1-2):41-51. PubMed ID: 23352853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
    Liu CP; Bach FH; Wu SK
    J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple regions of HLA-DR beta 1 chains determine polymorphic epitopes recognized by monoclonal antibodies.
    Alber CA; Watts R; Klohe EP; Drover S; Marshall WH; Radka SF; Karr RW
    J Immunol; 1989 Oct; 143(7):2248-55. PubMed ID: 2476501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
    Merkenschlager M; Altmann DM; Ikeda H
    J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of polymorphic monoclonal antibody epitopes to the first and second domains of HLA-DR beta-chains by site-directed mutagenesis.
    Maurer D; Gorski J
    J Immunol; 1991 Jan; 146(2):621-6. PubMed ID: 1702809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens.
    El-Awar N; Terasaki PI; Cai J; Deng CT; Ozawa M; Nguyen A; Lias M; Conger N
    Clin Transpl; 2009; ():295-321. PubMed ID: 20524293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the amino acid residues contributing to monoclonal antibody-defined DQw1 epitopes.
    Nordwig H; Kwok WW; Johnson JP
    Hum Immunol; 1991 Jun; 31(2):81-5. PubMed ID: 1712350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of the HLA molecular structure to transplantation.
    Park MS; Terasaki PI; Barbetti A; Han H; Cecka JM
    Clin Transpl; 1988; ():301-28. PubMed ID: 2484900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules.
    Tanigaki N; Tosi R; Parodi B; Sorrentino R; Ferrara GB; Strominger JL
    Eur J Immunol; 1987 Jun; 17(6):743-50. PubMed ID: 2439347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class II DQ epitopes.
    Deng CT; Cai J; Tarsitani C; El-Awar N; Lachmann N; Ozawa M
    Clin Transpl; 2006; ():115-22. PubMed ID: 18365373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR antibody epitopes.
    Cai J; Kohanof S; Terasaki PI
    Clin Transpl; 2006; ():103-14. PubMed ID: 18365372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry.
    Duquesnoy RJ; Marrari M; Tambur AR; Mulder A; Sousa LC; da Silva AS; do Monte SJ
    Hum Immunol; 2014 Nov; 75(11):1097-103. PubMed ID: 25305456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the DRw10 DR beta 1-chain allele as encoding a polymorphic class II major histocompatibility complex epitope otherwise restricted to DR beta 2 molecules of the DRw53 type.
    Matsuyama T; Winchester R; Lee S; Shookster L; Nunez-Roldan A
    J Immunol; 1988 Jan; 140(2):537-43. PubMed ID: 2447181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).
    Kuwana M; Kaburaki J; Okano Y; Inoko H; Tsuji K
    J Clin Invest; 1993 Sep; 92(3):1296-301. PubMed ID: 7690776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.